Blood Components and Cancer Diagnosis, Treatment and Prognosis :: Special Issue

About This Special Issue

With the development of society and the improvement of people's living habits, the incidence of cancer is getting higher and higher all over the world, which is a serious threat to human health. Therefore, it is of great significance to explore economical and convenient obtained markers for early diagnosis, therapeutic efficacy evaluation and prognosis evaluation of tumors.

The primary goal of this special issue is to providing a unique forum for researchers, scholars and practitioners to concern dynamic and rapid evolution of knowledge in the oncology and cancer field. We invite contributions that explore biomarkers associated with tumor diagnosis, treatment efficacy evaluation and prognosis evaluation with particular interest in economical and convenient obtained blood components.

Types of articles welcomed: Original research articles, review articles, case studies, etc.

Through this special issue, we aim to found more convenient methods for clinical cancer treatment and provide new ideas for future basic and clinical researches. We welcome researchers from various disciplines to provide interdisciplinary perspectives on the association of blood components and tumors. Your contributions will play a crucial role in advancing knowledge in this field.

Potential topics include, but are not limited to:

Blood Cells as Tumor Biomarkers
Blood Components, such as, Ldh, Alp and so on, as Tumor Markers
The Association of the Ratio of Blood Components with Tumors
The Association of the Combination of Blood Components and Traditional Tumor Marker with Tumors

Lead Guest Editor

Huan Zhang

Department of Radiotherapy, General Hospital of Southern Theater Command, Guangzhou, China

Guest Editors

Hao Hu

Department of Respiratory, General Hospital of Southern Theater Command, Guangzhou, China
Linxin Zheng

Department of Respiratory, General Hospital of Southern Theater Command, Guangzhou, China
Weifeng Li

Department of Respiratory, General Hospital of Southern Theater Command, Guangzhou, China
Zhuocai Wang

Department of Pathology, General Hospital of Southern Theater Command, Guangzhou, China
Min Wu

Magnetic Resonance Center, West China Hospital of Sichuan University, Chengdu, China
Huanji Xu

Department of Oncology, West China Hospital of Sichuan University, Chengdu, China

Manuscript Submission

Submitting your research to special issue is a simple and efficient process. Here are three submission options available:

1

Option 1: Quick Submission

Our Quick Submission tool provides a fast and uncomplicated way for you to submit your manuscripts.

Selected Special Issue:*

Special Issue Title	Article Processing Charge
Blood Components and Cancer Diagnosis, Treatment and Prognosis	970 USD

Article Title: *

Upload Manuscript:*

Upload

1. Allow only .doc, .docx and .tex format.
2. Files should not exceed 20MB.

Article Type: *

First Name:*

Last Name:*

Email Address:*

A follow-up email will be sent to the given email address within 3 working days.

Verification Code: *

Renew

2

Option 2: Online Submission

Submit your manuscript via our online submission system.

	For unregistered users, please register at https://sso.sciencepg.com/register
	For registered users, please log in at https://sso.sciencepg.com/login

Once you're logged in, click on "Submit to Special Issue" under the "Submission" section. Follow the system prompts to successfully complete the submission.

3

Option 3: Email Submission

You can submit your manuscript directly via email to submission@sciencepg.com

Please type "Blood Components and Cancer Diagnosis, Treatment and Prognosis Manuscript Submission" as the subject of your email.

International Journal of Clinical Oncology and Cancer Research

Blood Components and Cancer Diagnosis, Treatment and Prognosis